arrow
M

Massimo Fabiani

Istituto Superiore di Sanità
H指数:37
被引数:4,991

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ultrasound-based population survey for abdominal cystic echinococcosis in Albania: Results from the NDTND project

基于超声的阿尔巴尼亚腹型囊性棘球蚴病人群调查:NDTND项目结果

2025-12-020
PRE
Effectiveness of the 2023 Autumn XBB.1.5 COVID-19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study

2023年秋季XBB.1.5 COVID-19加强针在2024年夏季于欧盟/欧洲经济区内的有效性:一项VEBIS电子健康记录网络研究

2025-11-280
OAAI
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23

2022/23年度在VEBIS-EHR网络中针对秋季加强针的两种COVID-19疫苗有效性估计方法的比较

2025-03-172
OAAI
Case-time series study on the short-term impact of meteorological factors on West Nile Virus incidence in Italy at the local administrative unit level, 2012 to 2021
2025-01-010
OAAI
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study
2024-11-251
OA
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021
2024-06-110
OAAI
Socioeconomic Inequalities in SARS-CoV-2 Infection and COVID-19 Health Outcomes in Urban Italy During the COVID-19 Vaccine Rollout, January-November 2021

2021年1月到11月新型冠状病毒肺炎疫苗推广期间意大利城市SARS-CoV-2感染和新型冠状病毒肺炎健康结果的社会经济不平等

2024-03-181
OAAI
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

≥ 65岁人群新型冠状病毒肺炎住院的相对疫苗有效性: 欧洲VEBIS网络的结果,2021年10月2023年7月

2024-01-041
OAAI
Unveiling the incidences and trends of the neglected zoonosis cystic echinococcosis in Europe: a systematic review from the MEmE project
2023-03-0130
OAAI
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022
2023-02-2316
OAAI
COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study

在拉齐奥地区 (意大利) 最大的卫生机构居民中,新型冠状病毒肺炎疫苗的覆盖率和SARS-CoV-2感染的有效性: 一项基于人群的队列研究

2022-06-017
PRE
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021

7月19日2021年12月12日,在意大利delta变体的主要循环期间,mRNA疫苗加强剂量对 ≥ 60岁和其他高危人群的SARS-CoV-2感染和严重新型冠状病毒肺炎的有效性

2022-04-156
OA
Lack of Evidence of Chikungunya Virus Infection among Blood Donors during the Chikungunya Outbreak in Lazio Region, Italy, 2017

2017年意大利拉齐奥地区基孔肯雅爆发期间,献血者中缺乏基孔肯雅病毒感染的证据

2022-03-163
OAAI
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study

意大利delta变体主要循环期间mRNA疫苗的有效性以及对SARS-CoV-2感染和严重新型冠状病毒肺炎的保护作用减弱: 回顾性队列研究

2022-02-1067
OAAI
Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020-January 2021
2022-01-0135
OAAI